Latest Articles
Ananda Pharma is on a very clear path to cannabis drug development - ICYMI - Proactive Investors USA
Ananda Pharma is on a very clear path to cannabis drug development - ICYMI Proactive Investors USA
Published: Dec. 24, 2024, 8:32 a.m.
Frankston Hospital Redevelopment Hits Major Milestone 11 December - Mirage News
Frankston Hospital Redevelopment Hits Major Milestone 11 December Mirage News
Published: Dec. 10, 2024, 11:36 p.m.
Ananda Developments reveals more promising data from lead asset, discusses next steps - Proactive Investors USA
Ananda Developments reveals more promising data from lead asset, discusses next steps Proactive Investors USA
Published: Dec. 9, 2024, 12:40 p.m.
Impact of Fibrosis and Myofibroblasts in Endometriosis and Pain Development - Physician's Weekly
Impact of Fibrosis and Myofibroblasts in Endometriosis and Pain Development Physician's Weekly
Published: Nov. 28, 2024, 2:54 p.m.
Ananda Developments hails publication of article in TIPS scientific journal - Proactive Investors UK
Ananda Developments hails publication of article in TIPS scientific journal Proactive Investors UK
Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments hails publication of article in TIPS scientific journal - Proactive Investors USA
Ananda Developments hails publication of article in TIPS scientific journal Proactive Investors USA
Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments hails publication of article in TIPS scientific journal - Proactive financial news
Ananda Developments hails publication of article in TIPS scientific journal Proactive financial news
Published: Nov. 25, 2024, 3:28 p.m.
Ananda Developments interims chart a period of significant progress - Proactive Investors UK
Ananda Developments interims chart a period of significant progress Proactive Investors UK
Published: Oct. 30, 2024, 7:37 a.m.
Ananda Developments interims chart a period of significant progress - Proactive Investors USA
Ananda Developments interims chart a period of significant progress Proactive Investors USA
Published: Oct. 30, 2024, 7:37 a.m.
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors - StreetInsider.com
IDEAYA Biosciences Announces IND-Clearance for Werner Helicase Development Candidate IDE275 (GSK959) for a Phase 1 Study in MSI-High Solid Tumors StreetInsider.com
Published: Oct. 29, 2024, 10:11 a.m.
Link copied to clipboard!